Search Results - "Fratte, Chiara Dalle"

Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip by Moro, Giulia, Fratte, Chiara Dalle, Normanno, Nicola, Polo, Federico, Cinti, Stefano

“…Point‐of‐care (PoC) testing is revolutionizing the healthcare sector improving patient care in daily hospital practice and allowing reaching even remote…”
Get full text

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes by Mezzalira, Silvia, De Mattia, Elena, Guardascione, Michela, Dalle Fratte, Chiara, Cecchin, Erika, Toffoli, Giuseppe

“…Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide, representing the third leading cause of cancer-related deaths. HCC genetic…”
Get full text

Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC by Tosello, Valeria, Grassi, Angela, Rose, Dominic, Bao, Loc Carlo, Zulato, Elisabetta, Dalle Fratte, Chiara, Polano, Maurizio, Del Bianco, Paola, Pasello, Giulia, Guarneri, Valentina, Indraccolo, Stefano, Bonanno, Laura

“…Liquid biopsy has recently emerged as an important tool in clinical practice particularly for lung cancer patients. We retrospectively evaluated cell-free DNA…”
Get full text

Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis by Dalle Fratte, Chiara, Polesel, Jerry, Gagno, Sara, Posocco, Bianca, De Mattia, Elena, Roncato, Rossana, Orleni, Marco, Puglisi, Fabio, Guardascione, Michela, Buonadonna, Angela, Toffoli, Giuseppe, Cecchin, Erika

“…Adequate imatinib plasma levels are necessary to guarantee an efficacious and safe treatment in gastrointestinal stromal tumor (GIST) and chronic myeloid…”
Get full text

Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA by Dietz, Steffen, Christopoulos, Petros, Yuan, Zhao, Angeles, Arlou Kristina, Gu, Lisa, Volckmar, Anna-Lena, Ogrodnik, Simon J., Janke, Florian, Dalle Fratte, Chiara, Zemojtel, Tomasz, Schneider, Marc A., Kazdal, Daniel, Endris, Volker, Meister, Michael, Muley, Thomas, Cecchin, Erika, Reck, Martin, Schlesner, Matthias, Thomas, Michael, Stenzinger, Albrecht, Sültmann, Holger

“…Targeted therapies (TKI) have improved the prognosis of ALK-rearranged lung cancer (ALK+ NSCLC), but clinical courses vary widely. Early identification and…”
Get full text

The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure by Gagno, Sara, Buonadonna, Angela, Dalle Fratte, Chiara, Guardascione, Michela, Zanchetta, Martina, Posocco, Bianca, Orleni, Marco, Canil, Giovanni, Roncato, Rossana, Cecchin, Erika, Toffoli, Giuseppe

“…Background Chronic oral anticancer therapies, are increasingly prescribed and present new challenges including the enhanced risk of overlooked drug-drug…”
Get full text

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib by Dalle Fratte, Chiara, Guardascione, Michela, De Mattia, Elena, Borsatti, Eugenio, Boschetto, Roberta, Farruggio, Angelo, Canzonieri, Vincenzo, Romanato, Loredana, Borsatti, Rachele, Gagno, Sara, Marangon, Elena, Polano, Maurizio, Buonadonna, Angela, Toffoli, Giuseppe, Cecchin, Erika

“…The standard of care for the first-line treatment of advanced gastrointestinal stromal tumor (GIST) is represented by imatinib, which is given daily at a…”
Get full text

The relevance of citizen involvement in Health Technology Assessment. A concrete application in the assessment of HPV co-testing in the Autonomous Province of Trento by Dalle Fratte, Chiara Francesca, Passerini, Adriano, Vivori, Cinzia, Dalla Palma, Paolo, Guarrera, Giovanni Maria

“…Background Specific programs have been developed in the latest decades to involve patients in Health Technology Assessments (HTAs). However, there are no…”
Get full text

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity by Fragoulakis, Vasileios, Roncato, Rossana, Fratte, Chiara Dalle, Ecca, Fabrizio, Bartsakoulia, Marina, Innocenti, Federico, Toffoli, Giuseppe, Cecchin, Erika, Patrinos, George P., Mitropoulou, Christina

“…Fluoropyrimidines (FLs) have been widely used for more than 60 years against a range of solid tumors and still remains the cornerstone for the treatment of…”
Get full text

Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation by Gagno, Sara, Fratte, Chiara Dalle, Posocco, Bianca, Buonadonna, Angela, Fumagalli, Arianna, Guardascione, Michela, Toffoli, Giuseppe, Cecchin, Erika

“…Tweetable abstract Present evidence supports the use of intensified pharmacologic monitoring of #imatinib including #TherapeuticDrugMonitoring and #PGx to…”
Get more information

CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients by Dalle Fratte, Chiara, Gagno, Sara, Roncato, Rossana, Polesel, Jerry, Zanchetta, Martina, Buzzo, Mauro, Posocco, Bianca, De Mattia, Elena, Borsatti, Rachele, Puglisi, Fabio, Foltran, Luisa, Guardascione, Michela, Buonadonna, Angela, Cecchin, Erika, Toffoli, Giuseppe

“…Aims Patients on treatment with oral fixed dose imatinib are frequently under‐ or overexposed to the drug. We investigated the association between the gene…”
Get full text

The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice by Toffoli, Giuseppe, Innocenti, Federico, Polesel, Jerry, De Mattia, Elena, Sartor, Franca, Dalle Fratte, Chiara, Ecca, Fabrizio, Dreussi, Eva, Palazzari, Elisa, Guardascione, Michela, Buonadonna, Angela, Foltran, Luisa, Garziera, Marica, Bignucolo, Alessia, Nobili, Stefania, Mini, Enrico, Favaretto, Adolfo, Berretta, Massimiliano, D'Andrea, Mario, De Paoli, Antonino, Roncato, Rossana, Cecchin, Erika

“…Lack of information on the clinical utility of preemptive DPYD screening before fluoropyrimidine treatment is a major barrier preventing its use in clinical…”
Get full text

Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip by Moro, Giulia, Fratte, Chiara Dalle, Normanno, Nicola, Polo, Federico, Cinti, Stefano

“…Point‐of‐care (PoC) testing is revolutionizing the healthcare sector improving patient care in daily hospital practice and allowing reaching even remote…”
Get full text

A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer by Dalle Fratte, Chiara, Mezzalira, Silvia, Polesel, Jerry, De Mattia, Elena, Palumbo, Antonio, Buonadonna, Angela, Palazzari, Elisa, De Paoli, Antonino, Belluco, Claudio, Canzonieri, Vincenzo, Toffoli, Giuseppe, Cecchin, Erika

“…Pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients is related to a favorable prognosis. The…”
Get full text

Association of Sodium-Glucose Cotransporter 2 Inhibitors with Osteomyelitis and Other Lower Limb Safety Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials by Nani, Alessandro, Carrara, Federica, Paulesu, Chiara Maria Eleonora, Dalle Fratte, Chiara, Padroni, Matteo, Enisci, Silvia, Bilancio, Maria Concetta, Romio, Maria Silvia, Bertuzzi, Federico, Pintaudi, Basilio

“…Our aim was to evaluate osteomyelitis and other major lower limb safety outcomes (i.e., peripheral artery disease or PAD, ulcers, atraumatic fractures,…”
Get full text

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy by De Mattia, Elena, Canzonieri, Vincenzo, Polesel, Jerry, Mezzalira, Silvia, Dalle Fratte, Chiara, Dreussi, Eva, Roncato, Rossana, Bignucolo, Alessia, Innocente, Roberto, Belluco, Claudio, Pucciarelli, Salvatore, De Paoli, Antonino, Palazzari, Elisa, Toffoli, Giuseppe, Cecchin, Erika

“…Identifying patients at risk of poor response to neoadjuvant chemoradiotherapy (nCRT) is an emerging clinical need in locally advanced rectal cancer (LARC)…”
Get full text

The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines by De Mattia, Elena, Roncato, Rossana, Dalle Fratte, Chiara, Ecca, Fabrizio, Toffoli, Giuseppe, Cecchin, Erika

“…Fluoropyrimidines (FP) are given in the combination treatment of the advanced disease or as monotherapy in the neo-adjuvant and adjuvant treatment of…”
Get full text

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy by Marini, Massimiliano, Videsott, Lodovica, Dalle Fratte, Chiara Francesca, Francesconi, Andrea, Bonvicini, Eleonora, Quintarelli, Silvia, Martin, Marta, Guarracini, Fabrizio, Coser, Alessio, Benetollo, Pier Paolo, Bonmassari, Roberto, Boriani, Giuseppe

“…Remote monitoring (RM) technologies have the potential to improve patient care by increasing compliance, providing early indications of heart failure (HF), and…”
Get full text

Robot-assisted laparoscopic prostatectomy: a costs and break-even point analysis for decision-making in a university hospital and a regional healthcare system in Northern Italy by Fabbro, Elisa, Crivellaro, Simone, Dalle Fratte, Chiara F., Vetrugno, Luigi, Adani, Gianluigi, Saule, Barbara, Drigo, Daniela, Zumerle, Giulia, Favaretti, Carlo, Guarrera, Giovanni M.

“…BACKGROUND: Robotic Assisted Radical Prostatectomy (RALP) is one of the most expensive urological innovations. Prices of the “Da Vinci System” range from…”
Get full text

Impact of IABCG2/I and IABCB1/I Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis by Dalle Fratte, Chiara, Polesel, Jerry, Gagno, Sara, Posocco, Bianca, De Mattia, Elena, Roncato, Rossana, Orleni, Marco, Puglisi, Fabio, Guardascione, Michela, Buonadonna, Angela, Toffoli, Giuseppe, Cecchin, Erika

“…Adequate imatinib plasma levels are necessary to guarantee an efficacious and safe treatment in gastrointestinal stromal tumor (GIST) and chronic myeloid…”
Get full text